Skip to main content

Day: April 16, 2026

Guardian Capital Announces April 2026 Cash Distributions for Guardian Capital ETFs

TORONTO, April 16, 2026 (GLOBE NEWSWIRE) — Guardian Capital LP (the “Manager”) announces the following regular cash distributions for the period ending April 30, 2026, in respect of the ETF series of the Guardian Capital funds listed below (the “Guardian Capital ETFs”). In each case, the distribution will be paid on April 30, 2026 to unitholders of record on April 24, 2026. The ex-dividend date in each case is anticipated to be April 24, 2026.Guardian Capital ETFs Series of ETF Units DistributionFrequency TradingSymbol Exchange Distribution Amount(per ETF Unit)GuardBondsTM 2026 Investment Grade Bond Fund ETF Units Monthly GBFC Cboe Canada CAD$0.0249GuardBondsTM 2027 Investment Grade Bond Fund ETF Units Monthly GBFD Cboe Canada CAD$0.0267GuardBondsTM 2028 Investment Grade Bond Fund ETF Units Monthly GBFE Cboe Canada CAD$0.0310GuardBondsTM...

Continue reading

Plato Gold Corp. Announces the Closing of the Sale of Timmins-Area Properties to Mayfair Gold Corp.

TORONTO, Ontario, April 16, 2026 (GLOBE NEWSWIRE) — Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”) announces that it has closed the transaction (the “Transaction”) annouced on April 2, 2026 with Mayfair Gold Corp. (“Mayfair”) pursuant to which Mayfair has acquired Plato’s interests in the Guibord, Marriott and Holloway properties (collectively, the “Properties”), all located in the Timmins, Ontario area, for total cash consideration of C$2.5 million (the “Cash Consideration”). The Cash Consideration has been placed into escrow, as further described in this news release. The Properties consist of mineral claims and mining leases located along and adjacent to the Destor–Porcupine structural corridor in the Timmins gold district. The transaction allows Plato to monetize non‑core...

Continue reading

MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)

Company entered into an asset purchase agreement with Johnson & Johnson (J&J) to acquire all interests in botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP) MeiraGTx intends to immediately pursue global regulatory filings for approval of bota-vecLONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) — MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced that it has entered into an asset purchase agreement with Johnson & Johnson* (J&J) to acquire all interests in bota-vec for the treatment of XLRP. “We are extremely pleased to have reacquired bota-vec for the treatment of XLRP,” said Alexandria Forbes, Ph.D., president and chief executive officer of MeiraGTx. “This is a unique opportunity to gain an...

Continue reading

Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2026

GREAT NECK, N.Y., April 16, 2026 (GLOBE NEWSWIRE) — Manhattan Bridge Capital, Inc. (Nasdaq: LOAN) (the “Company”) announced today that its net income for the three months ended March 31, 2026 was approximately $1,274,000, or $0.11 per share (based on approximately 11.4 million weighted-average outstanding common shares), compared to approximately $1,373,000, or $0.12 per share (based on approximately 11.4 million weighted-average outstanding common shares) for the same period in 2025, representing a decrease of $99,000, or 7.2%. The decrease was primarily attributable to lower revenue, partially offset by reduced interest expense, reflecting lower average borrowings under the Company’s credit facility and decreased prevailing SOFR rates. Total revenues for the three months ended March 31, 2026 were approximately $2,068,000, compared...

Continue reading

Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency

EMERYVILLE, Calif., April 16, 2026 (GLOBE NEWSWIRE) — Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients, today announced a publication in Nature Structural & Molecular Biology highlighting the discovery and detailed characterization of MG119-28, a compact CRISPR nuclease with superior editing efficiency relative to previously identified compact nucleases. The publication, titled “Comparative characterization of Cas12f orthologs reveals mechanistic features underlying enhanced genome editing efficiency” highlights the potential of MG119-28 (formally named Al3Cas12f) to overcome low editing efficiency in mammalian systems of previously identified compact nucleases from the Cas12f class. The...

Continue reading

Abaxx to Launch World’s First Exchange-Traded Solar Futures Contract

Developed in partnership with Enwex, the contract introduces an exchange-cleared benchmark for hedging weather-driven volume risk in Germany’s expanding solar fleet TORONTO, April 16, 2026 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company, indirect majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore”), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), and producer of the SmarterMarkets™ Podcast, today announced that Abaxx Exchange will expand its weather-indexed product suite with the launch of Enwex Germany Solar (GSM) futures, available for trading on April 23, 2026. For the first time in 2025, solar power produced more electricity in Germany than...

Continue reading

Adlai Nortye Announces $150.0 Million Private Placement Equity Financing

SINGAPORE and NORTH BRUNSWICK, N.J., April 16, 2026 (GLOBE NEWSWIRE) — Adlai Nortye Ltd. (Nasdaq: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, today announced that it has entered into a securities purchase agreement for a private investment in public equity financing that is expected to result in gross proceeds of approximately $150.0 million, before deducting placement agent fees and other private placement expenses. The oversubscribed transaction includes participation from both new and existing institutional investors. New investors include Soleus Capital, Perceptive Advisors, ADAR1 Capital Management, MPM BioImpact, Octagon Capital, Eventide Asset Management and Kalehua Capital, DAFNA Capital Management, etc., with additional participation...

Continue reading

Cielo Closes Strategic Asset Acquisition and Announces Intention to Appoint Chief Operating Officer and Chief Development Officer

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, April 16, 2026 (GLOBE NEWSWIRE) — Cielo Waste Solutions Corp. (TSXV: CMC; OTCQB: CWSFF) (“Cielo” or the “Company”) is pleased to announce that it has closed the previously announced acquisition (the “Acquisition”) of certain proprietary project development and evaluation assets from CDL Biofuels Ltd. (“CDL Biofuels”), a subsidiary of Canadian Discovery Ltd. (“CDL”), pursuant to an asset purchase agreement dated April 15, 2026 (the “APA”). Transaction Overview Pursuant to the APA, Cielo acquired from CDL Biofuels a suite of proprietary, non-public project development and evaluation assets, including databases, data sets, models, analytical tools, technical reviews, and related intellectual property...

Continue reading

Safe Harbor Financial Fourth Quarter and Full Year 2025 Results, Highlighting Sequential 12% Sales Growth, Balance Sheet Transformation and Operational Progress

Eliminated substantially all of the Company’s debt, ended the year with $6.8 million in Cash and $8.2 million of Stockholders’ Equity. Fourth Quarter Revenue increased 12% sequentially, and Fourth Quarter Net Loss was $0.6 million including a $0.5 million success-based employee bonus expense. Updated and extended agreement with Partner Colorado Credit Union (“PCCU”) through 2031; expected to increase cash flow by over $10 million over the period, driving a 70% increase in loan program revenue in the fourth quarter versus the third quarter.DENVER, April 16, 2026 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a Safe Harbor Financial (“Safe Harbor” or “the Company”) (NASDAQ: SHFS), a leading fintech platform serving the banking, lending, and financial services needs of the regulated cannabis and hemp industries, today announced its...

Continue reading

Kraken Robotics Reports 2025 Financial Results

ST. JOHN’S, Newfoundland and Labrador, April 16, 2026 (GLOBE NEWSWIRE) — Kraken Robotics Inc. (“Kraken” or the “Company”) (TSX-V: PNG, OTCQB: KRKNF), announced it has filed its financial results for the fourth quarter and year ended December 31, 2025 (“Q4 2025”). Please refer to the audited consolidated financial statements of the Company for the fiscal years ended December 31, 2025 and 2024, management’s discussion and analysis for the three and twelve months ended December 31, 2025 (“MD&A”) and the annual information form of the Company for the year ended December 31, 2025, each filed on SEDAR+ at www.sedarplus.ca, for more information. Certain preliminary 2025 year-end results and 2026 guidance were already announced in the news release of the Company dated March 3, 2026 (the “March 3 News Release”), together with...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.